State Board of Administration of Florida Retirement System’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37.3M Sell
112,718
-1,885
-2% -$641K 0.07% 244
2025
Q4
$45.6M Sell
114,603
-2,623
-2% -$1.16M 0.08% 203
2025
Q3
$53.5M Sell
117,226
-9,824
-8% -$4M 0.09% 188
2025
Q2
$41.4M Buy
127,050
+1,810
+1% +$501K 0.07% 237
2025
Q1
$33.8M Hold
125,240
0.07% 250
2024
Q4
$29.5M Sell
125,240
-4,177
-3% -$1.1M 0.06% 291
2024
Q3
$35.6M Sell
129,417
-5,930
-4% -$1.54M 0.07% 270
2024
Q2
$32.9M Sell
135,347
-1,675
-1% -$264K 0.06% 281
2024
Q1
$27.4M Buy
137,022
+1,135
+0.8% +$189K 0.06% 301
2023
Q4
$26M Buy
135,887
+4,677
+4% +$797K 0.05% 325
2023
Q3
$23.2M Sell
131,210
-5,350
-4% -$1.02M 0.05% 327
2023
Q2
$25.9M Sell
136,560
-462
-0.3% -$91.6K 0.06% 323
2023
Q1
$27.4M Sell
137,022
-10
-0% -$2.1K 0.06% 305
2022
Q4
$32.6M Sell
137,032
-1,760
-1% -$375K 0.08% 262
2022
Q3
$27.8M Buy
138,792
+195
+0.1% +$37.2K 0.07% 274
2022
Q2
$20.2M Sell
138,597
-6,422
-4% -$911K 0.05% 366
2022
Q1
$23.7M Sell
145,019
-2,974
-2% -$453K 0.05% 378
2021
Q4
$25.1M Sell
147,993
-2,091
-1% -$389K 0.05% 393
2021
Q3
$28.3M Sell
150,084
-2,788
-2% -$523K 0.06% 343
2021
Q2
$25.9M Sell
152,872
-1,904
-1% -$279K 0.05% 380
2021
Q1
$21.9M Sell
154,776
-5,450
-3% -$820K 0.04% 418
2020
Q4
$20.8M Buy
160,226
+9,617
+6% +$1.28M 0.04% 412
2020
Q3
$21.9M Buy
150,609
+2,970
+2% +$422K 0.05% 347
2020
Q2
$21.9M Buy
147,639
+3,638
+3% +$490K 0.05% 328
2020
Q1
$15.7M Buy
144,001
+4,732
+3% +$546K 0.05% 356
2019
Q4
$16M Buy
139,269
+2,786
+2% +$278K 0.04% 437
2019
Q3
$11M Buy
136,483
+3,310
+2% +$262K 0.03% 542
2019
Q2
$9.66M Buy
133,173
+8,035
+6% +$616K 0.03% 606
2019
Q1
$11.7M Sell
125,138
-550
-0.4% -$46K 0.03% 515
2018
Q4
$9.16M Buy
125,688
+5,800
+5% +$446K 0.03% 548
2018
Q3
$10.5M Sell
119,888
-508
-0.4% -$51.1K 0.03% 570
2018
Q2
$11.9M Buy
120,396
+2,570
+2% +$255K 0.03% 526
2018
Q1
$14M Buy
117,826
+1,606
+1% +$207K 0.04% 470
2017
Q4
$14.8M Buy
116,220
+7,272
+7% +$914K 0.04% 471
2017
Q3
$12.8M Buy
108,948
+240
+0.2% +$20.5K 0.03% 496
2017
Q2
$8.67M Buy
108,708
+2,200
+2% +$141K 0.02% 619
2017
Q1
$5.46M Sell
106,508
-1,990
-2% -$92K 0.02% 756
2016
Q4
$4.06M Sell
108,498
-2,431
-2% -$102K 0.01% 841
2016
Q3
$7.52M Sell
110,929
-1,760
-2% -$124K 0.02% 634
2016
Q2
$6.25M Buy
112,689
+20,574
+22% +$1.3M 0.02% 682
2016
Q1
$5.78M Sell
92,115
-4,770
-5% -$317K 0.02% 665
2015
Q4
$9.12M Sell
96,885
-4,445
-4% -$412K 0.03% 507
2015
Q3
$8.14M Buy
101,330
+1,276
+1% +$142K 0.03% 543
2015
Q2
$12M Buy
100,054
+8,659
+9% +$1.03M 0.04% 442
2015
Q1
$9.54M Sell
91,395
-2,352
-3% -$238K 0.03% 544
2014
Q4
$9.09M Buy
93,747
+119
+0.1% +$11K 0.03% 576
2014
Q3
$7.31M Buy
93,628
+28,216
+43% +$1.82M 0.02% 654
2014
Q2
$4.13M Buy
65,412
+14,763
+29% +$877K 0.01% 894
2014
Q1
$3.4M Hold
50,649
0.01% 927
2013
Q4
$3.26M Sell
50,649
-896
-2% -$53.5K 0.01% 949
2013
Q3
$3.3M Buy
51,545
+150
+0.3% +$7.48K 0.01% 947
2013
Q2
$1.59M Buy
+51,395
New +$1.37M 0.01% 1225

Other funds holding ALNY

State Board of Administration of Florida Retirement System's ALNY Position: Q1 2026 in Review

State Board of Administration of Florida Retirement System reduced its Alnylam Pharmaceuticals (ALNY) stake by 1.6% in Q1 2026, selling an estimated $641K and leaving 112,718 shares worth $37.3M. The position accounts for 0.07% of the portfolio, ranked #244.

State Board of Administration of Florida Retirement System first reported a position in ALNY in Q2 2013 and has held it in 52 quarters since. The position peaked at $53.5M in Q3 2025. 789 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

  • State Board of Administration of Florida Retirement System held 112,718 shares of Alnylam Pharmaceuticals worth $37.3M as of Q1 2026.
  • State Board of Administration of Florida Retirement System sold 1,885 Alnylam Pharmaceuticals shares in Q1 2026, an estimated $641K.
  • Alnylam Pharmaceuticals made up 0.07% of State Board of Administration of Florida Retirement System's portfolio in Q1 2026, its #244 holding.
  • State Board of Administration of Florida Retirement System first reported a position in Alnylam Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • State Board of Administration of Florida Retirement System's Alnylam Pharmaceuticals position peaked at $53.5M in Q3 2025.
  • 789 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q1 2026, filed 8 May 2026.